Primary Health Centres can be approached for hepatitis B vaccine, says TN govt
Several private hospitals across the State have been facing short supply of hepatitis B vaccines especially for vaccinating their healthcare workers and patients such as those on dialysis. A private hospital in Chennai that administers both pentavalent and hexavalent vaccines containing hepatitis B under UIP currently has adequate stock.
The Health department said that there was no shortage of the vaccine in government hospitals. Health Minister Ma. Subramanian recently said that the State had a stock of 6,21,320 doses of the vaccine at present. This was adequate to meet the requirements for 8.5 months. Similarly, 5,52,100 pentavalent vaccines were also available to take care of the needs for the next 2.5 months.
T. S. Selvavinayagam, Director of Public Health, reiterated that nearby PHCs can be approached for vaccinating children as per UIP schedule.
A doctor, who has been closely following the hepatitis B vaccine situation, said that Hepatitis B vaccination in adults is always challenging. It was being implemented by covering key populations who have been screened and found as hepatitis negative before vaccination, he said.
Open Vial Policy for hepatitis B vaccine to prevent wastage is one of the main challenges. This allows usage of an open vial for up to 28 days. 'The vaccine is administered to the targeted groups (among adults) after hepatitis B testing. In fact, the test kits are also in short supply' he said.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hindu
2 hours ago
- The Hindu
‘Hepatitis is a silent threat that affects all age groups'
Hepatitis is no longer a disease that affects only a specific group, it is a silent threat that spans across ages, from children to adults. On July 28, observed as World Hepatitis Day, doctors in Hyderabad have raised an alarm on the growing burden of liver disease in India, and have called for urgent awareness, early screening, and preventive action. Hepatitis, which refers to inflammation of the liver, can be caused by a wide range of factors, including viral infections, alcohol consumption, unhealthy diet, obesity, and even certain medications. In India alone, over 40 million people are living with Hepatitis B, and up to 12 million with Hepatitis C, most of them unaware of the problem. The virus often stays dormant for years, silently damaging the liver, and only revealing itself when the damage is severe, said Kavya Dendukuri, Lead Transplant Hepatologist at Gleneagles Hospital. She further added that hepatitis is not a single disease. It includes types, A, B, C, D, and E, each with its own causes and modes of transmission. Hepatitis A and E spread through contaminated food and water, while B and C are transmitted through infected blood, unprotected sex, shared needles, or from mother to child. Hepatitis D occurs only in those already infected with B. 'Earlier, hepatitis was largely seen in the elderly due to alcohol or long-standing infections. Now, we are seeing non-alcoholic fatty liver disease in people as young as 40 due to sedentary lifestyles, poor diets, and obesity.' said V.R. Sumanth Kumar and Tejaswini Tumma, Consultant Gastroenterologists at Kamineni Hospitals. Auto-immune hepatitis, drug-induced hepatitis, and alcohol-related liver inflammation are also on the rise. 'Many people don't realise that certain herbal medicines, painkillers, or even overdosing on paracetamol can trigger serious liver inflammation,' warnedSrinivasa Reddy G from Star Hospitals. One of the greatest challenges in tackling hepatitis is that most people show no symptoms until the disease is advanced. Common signs, when they do appear include fatigue, nausea, abdominal pain, loss of appetite, dark urine, pale stools, and jaundice. But by then, the liver may already be scarred. Akash Chaudhary from CARE Hospitals shared that hepatitis is preventable and, in many cases, curable. Vaccines are available for Hepatitis A and B, and all new-borns and high-risk adults should receive them. 'Treatments for Hepatitis C, once considered expensive and complex, now involves short-term oral medication with near-total cure rates. Hepatitis B can be managed through daily anti-viral tablets, which have become highly affordable,' he added.
The Hindu
2 hours ago
- The Hindu
24 in-service super speciality seats remain vacant; Minister seeks stray round of counselling
With 24 in-service super speciality medical seats remaining vacant, Health Minister Ma. Subramanian has urged the Union Health Minister to permit the State government to conduct an extended stray round of counselling for in-service candidates. In a letter to Union Health Minister J.P. Nadda on Monday, Mr. Subramanian said that as per the directions of the Supreme Court, 50% of super speciality seats in government medical colleges in Tamil Nadu are reserved for in-service candidates. Now, 24 in-service seats remain vacant. Due to changes in the counselling guidelines, including a notification from the Directorate General of Health Services (DGHS) dated June 21 permitting upgradation in the stray round, the State's Selection Committee has received representations seeking an additional round of counselling to fill these vacancies. He requested the Union Minister's intervention to permit the State government to conduct an extended stray round of counselling for in-service candidates to fill up the 24 vacancies in super speciality courses and to complete the process on or before August 5. This, he said, will help strengthen the availability of specialists in government institutions across the State. This year, the State had to surrender 145 super speciality medical seats meant for in-service candidates to the All India Quota counselling before conducting its second round of counselling. This came after the DGHS asked the State to revert the vacant in-service seats to the Medical Counselling Committee for all-India counselling. The Minister had written to the Union Health Minister regarding the surrender of super speciality seats on June 11.
United News of India
3 hours ago
- United News of India
World Hepatitis Day 2025: Only 3 pc Hepatitis B Patients in India aware of their ailment
New Delhi, July 28(UNI) Just about three per cent of Hepatitis B Patients in India are aware about their ailment, and less than one per cent of them receive treatment, said Rajesh Bhushan, Former Secretary, Ministry of Health & Family Welfare, Government of India today. "Only 3 pc of hepatitis B patients in India are aware of their condition, and less than 1% of eligible individuals are receiving antiviral treatment. These are not just statistics, they reflect a silent public health crisis that demands immediate, coordinated action,' said Bhushan while addressing the 'Illness to Wellness' Awareness Conference held in New Delhi on the occasion of World Hepatitis Day. The Illness to Wellness Foundation organised the conference in New Delhi today, to mark World Hepatitis Day, centred around the theme 'Prevention, Diagnosis, and Treatment for Hepatitis.' The event brought together medical experts, policymakers, and public health advocates to highlight the urgency of tackling India's growing hepatitis burden through policy reform, improved access, and greater public awareness. Bhushan underscored the need for bold, systemic efforts. He identified five urgent priorities to address the increasing hepatitis cases - expanded screening and surveillance, ensuring timely birth-dose vaccination, decentralisation of treatment access, driving community-level awareness, and using real-time data for action. He also stressed the need for robust partnerships and said, 'Strategic interventions must be driven not only by the government but also through collaboration with civil society, the private sector, public health professionals, and the medical community'. During the session, health experts highlighted alarming global data that only 45 per cent of new-borns receive the hepatitis B vaccine within 24 hours of birth, which is a critical gap in prevention. They also emphasised that WHO's 2030 target to eliminate hepatitis, which calls for a 90% reduction in new infections and 80% treatment coverage, hinges on several key strategies: universal vaccination, timely diagnosis, people-centred care, and widespread public awareness to combat stigma. UNI RKM SSP
